packageQuizartinib

quizartinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Quizartinib is a protein kinase inhibitor used to treat acute myeloid leukemia. It is an approved medicine, authorised in the European Union, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q7272714 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:quizartinib
ATC codes:L01EX11, L01XE
DrugBank:DB12874
PubChem CID:24889392
ChEBI:90217
Wikidata:Q7272714
formula:C29H32N6O4S
molar mass:560.673 g/mol (PubChem CID 24889392)
logP:5.6 (Drugs.Common 25.09, not verified)

Metabolites

AC886AC886576.67 g/mol (paper)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
AC886metabolite: AC886